Option chain shows key data for Elite Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Elite Pharmaceuticals.

Elite Pharmaceuticals (OTC:ELTP) Stock, Option Chain

Elite Pharmaceuticals

Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.

Earnings

News

Pre-Market Outlook

Markets

CMCM

ELTP

MMMB

SHIP

Earnings Scheduled For June 14, 2019

ELITE PHARMS INC by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Inc

Press Releases

Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information

Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line

Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets

Comments

Elite Pharmaceuticals

Elite Pharmaceuticals (ELTP) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell